ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of ...
News-Medical.Net on MSN
Minimal residual disease monitoring can transform breast cancer care
Despite major therapeutic advances, breast cancer remains prone to recurrence, particularly in patients with early-stage ...
The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...
24/7 Wall St. on MSN
Ripple–Mastercard Pilot Taps XRP Ledger for Card Payments—Why a $20 Trillion Market Is in Focus
Credit card payments move trillions of dollars every year, yet the way those transactions settle has barely changed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback